SI

Sofinnova Investments Portfolio holdings

AUM $1.47B
1-Year Est. Return 17.43%
This Quarter Est. Return
1 Year Est. Return
+17.43%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.47B
AUM Growth
+$144M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
73
New
Increased
Reduced
Closed

Top Buys

1 +$70M
2 +$49.3M
3 +$46.3M
4
LLY icon
Eli Lilly
LLY
+$34.5M
5
UTHR icon
United Therapeutics
UTHR
+$34.1M

Top Sells

1 +$111M
2 +$50.6M
3 +$47.6M
4
BPMC
Blueprint Medicines
BPMC
+$23.1M
5
BMY icon
Bristol-Myers Squibb
BMY
+$22.7M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTRA icon
1
Natera
NTRA
$26.4B
$262M 16.02%
1,550,280
GILD icon
2
Gilead Sciences
GILD
$150B
$116M 7.12%
1,050,308
+631,408
LLY icon
3
Eli Lilly
LLY
$740B
$75.6M 4.63%
97,018
+44,218
JAZZ icon
4
Jazz Pharmaceuticals
JAZZ
$8.4B
$73.7M 4.51%
694,096
+184,046
VERA icon
5
Vera Therapeutics
VERA
$1.86B
$65.8M 4.03%
2,793,987
ABBV icon
6
AbbVie
ABBV
$403B
$49.3M 3.02%
+265,850
BSX icon
7
Boston Scientific
BSX
$152B
$46.3M 2.83%
+431,200
DXCM icon
8
DexCom
DXCM
$27.9B
$45.7M 2.8%
523,694
+127,719
IDYA icon
9
IDEAYA Biosciences
IDYA
$2.49B
$45.1M 2.76%
2,147,795
-474,397
BBIO icon
10
BridgeBio Pharma
BBIO
$10.3B
$42.9M 2.62%
993,093
+258,866
ISRG icon
11
Intuitive Surgical
ISRG
$194B
$38.4M 2.35%
70,642
+58,658
RYTM icon
12
Rhythm Pharmaceuticals
RYTM
$7.34B
$37M 2.26%
586,010
+139,171
AVBP icon
13
ArriVent BioPharma
AVBP
$734M
$36.9M 2.26%
1,696,752
ROIV icon
14
Roivant Sciences
ROIV
$12.4B
$34.8M 2.13%
3,088,814
+1,809,304
SLNO icon
15
Soleno Therapeutics
SLNO
$3.41B
$34.8M 2.13%
415,219
-69,252
UTHR icon
16
United Therapeutics
UTHR
$18.9B
$34.1M 2.08%
+118,513
INSM icon
17
Insmed
INSM
$33.7B
$31.6M 1.93%
313,923
+9,669
AKRO icon
18
Akero Therapeutics
AKRO
$4.31B
$29.3M 1.79%
548,788
+38,768
SUPN icon
19
Supernus Pharmaceuticals
SUPN
$2.96B
$25.2M 1.54%
799,253
+278,575
ANAB icon
20
AnaptysBio
ANAB
$951M
$22.9M 1.4%
1,032,362
-127,671
RAPP
21
Rapport Therapeutics
RAPP
$1.2B
$22.7M 1.39%
1,995,594
QURE icon
22
uniQure
QURE
$3.76B
$21.7M 1.33%
1,558,356
+1,012,585
MRUS icon
23
Merus
MRUS
$7.19B
$21.3M 1.3%
+404,562
AZN icon
24
AstraZeneca
AZN
$259B
$20.5M 1.26%
+293,661
PTCT icon
25
PTC Therapeutics
PTCT
$5.27B
$18.4M 1.12%
375,939
-203,400